300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Platforms
Enterprise Software
Local
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Art
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Real Estate
Sustainability
Hardware
Biotech
Sporting Goods
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Philippines
Malaysia
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Europe
Austria
Azerbaijan
Bulgaria
Ecuador
Qatar
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Angola
Belarus
Finland
Cyprus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Steve Pacelli, Angel Investor at Dexcom Ventures

Steve Pacelli

Angel Investor · at Dexcom Ventures

San Diego, United States

Steve Pacelli is a Series A investor at Dexcom Ventures in San Diego focused on Medical Device and Medical. More than 25 years of medical technology experience, including serving as CEO of DexCom, Inc., Senior Vice President and President Vascular for Medtronic, Inc., and Vice President of Marketing for Arterial Vascular Engineering.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Steve Pacelli invests in

Medical DeviceMedicalmHealthOncologyWearables

Stages Steve Pacelli invests in

Series A

Countries Steve Pacelli invests in

IrelandUnited States

Round sizes

Series A $2.5M–$13M

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2.5M–$13M

Investment Focus

Industry

  • Medical Device 2 (100%)
  • Medical 1 (50%)
  • mHealth 1 (50%)
  • Oncology 1 (50%)
  • Wearables 1 (50%)
See all 10 industries →

Country

  • Ireland 1 (50%)
  • United States 1 (50%)

Investments

CompanyDescriptionRoundLinks
Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. $2.5M / Series A / Dec 04, 2024
Epitel is a digital health company developing a wearable, wireless EEG monitoring platform to provide accessible, affordable, and reliable for seizure detection. $12.5M / Series A / Feb 16, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Platforms
Enterprise Software
Local
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Fitness
Marketplace
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Blockchain
Facebook
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Art
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Real Estate
Sustainability
Hardware
Biotech
Sporting Goods
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Poland
Puerto Rico
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Philippines
Malaysia
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Portugal
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Spain
Albania
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Europe
Austria
Azerbaijan
Bulgaria
Ecuador
Qatar
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Angola
Belarus
Finland
Cyprus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Steve Pacelli invest in?

Steve Pacelli invests primarily in Medical Device, Medical and mHealth startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Steve Pacelli's check size?

Steve Pacelli typically joins rounds of $2.5M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Steve Pacelli participates in.

How do I contact Steve Pacelli?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Steve Pacelli last invest?

The most recent investment recorded for Steve Pacelli closed in Dec 2024. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Steve Pacelli Steve Pacelli Find email